We’re delighted to add a summary of a lunch symposium at the Australian & New Zealand Childrens Haematology/Oncology Group (ANZCHOG) Scientific Meeting.
The discussion was presented by Dr Theodore Laetsch, Associate Professor of Paediatrics at the Children’s Hospital of Philadelphia and the University of Pennsylvania on the efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase fusion-positive cancer.
Please login below to download this issue (PDF)